EUVIMEDEUVIMED entdecken
Crossref

Aqueous remote loading of setmelanotide in poly(lactic-co-glycolic acid) microspheres for long-term obesity treatment

Shuying Wang, Griffin Downing, Karl F Olsen, Tomi K Sawyer, Roger D Cone, Steven P Schwendeman

Journal of Controlled Release · 2023

DOI: 10.1016/j.jconrel.2023.09.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2023. Verfasst von Shuying Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences and the Biointerfaces Institute, University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Ann…. Hauptthemen laut MEDLINE: Polyglycolic Acid, Lactic Acid. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: NIDDK NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Setmelanotide (Imcivree™) was developed as a daily injectable therapeutic peptide for the treatment of rare forms of syndromic obesity, such as POMC deficiency and leptin receptor deficiency. The important option of poly(lactic-co-glycolic acid) (PLGA) controlled release microspheres has become more attractive for this class of drugs upon the discovery that net positively charged peptides can be remote-loaded rapidly from aqueous peptide solution into blank microspheres at high loading and encapsulation efficiency. Here we sought to remote-load setmelanotide in PLGA microspheres and examine its potential for long-term controlled release and body weight control. The influence of PLGA microsphere porosity was investigated with respect to morphology, drug loading, and in vitro release profiles. Increased density of the microspheres inhibited the progress of encapsulation of the dicationic peptide. A diet-induced obese murine model was then used to determine the pharmacokinetic profile and to evaluate long-term efficacy of an optimal formulation. Remote loaded PLGA formulations encapsulated setmelanotide as high as ∼63% (∼6.3% w/w loading) and exhibited slow and continuous peptide release over ∼6 weeks in vitro largely independent of microsphere porosity. The obtained in vivo release pattern from deconvolution of the pharmacokinetics after subcutaneous microsphere injection was consistent with the in vitro release profile but with a lower initial burst release and overall slightly faster release rate. After a single injection of remote-loaded setmelanotide, continuous long-term inhibition of food intake and body weight control was observed over 17 and 30 days, respectively. The improvement in body weight control over drug-free microsphere vehicle-treated control groups matched the observed PK profile. This study provides the first report of long-acting release formulation for 1-month controlled release of setmelanotide and body weight control in a diet induced obese murine model, and supports the further development of long-acting treatment options for obese patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polyglycolic AcidLactic AcidHumansMiceAnimalsPolylactic Acid-Polyglycolic Acid CopolymerMicrospheresDrug CarriersDelayed-Action PreparationsGlycolsDisease Models, Animalalpha-MSHObesityBody WeightParticle Size

Stichwörter der Autor:innen

Controlled releaseLong actingMelanocortin peptideObesity treatmentPLGARemote loadingSetmelanotide

Substanzen

Polylactic Acid-Polyglycolic Acid CopolymerPolyglycolic AcidLactic AcidDrug CarriersDelayed-Action PreparationsGlycolssetmelanotidealpha-MSH

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences and the Biointerfaces Institute, University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Ann Arbor, MI 48109, USA.
  • Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA; Department of Molecular, Cellular, and Developmental Biology, University of Michigan, Ann Arbor, MI 48109, USA.
  • Courage Therapeutics, 64 Homer St., Newton, MA, USA.
  • Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA; Department of Molecular, Cellular, and Developmental Biology, University of Michigan, Ann Arbor, MI 48109, USA; Department of Molecular and Inte…
  • Department of Pharmaceutical Sciences and the Biointerfaces Institute, University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Ann Arbor, MI 48109, USA. Electronic address: sschwende@gmail.com.

Förderung

  • NIDDK NIH HHS
  • National Institutes of Health

Zitieren

APA

Wang, S., Downing, G., Olsen, K. F., Sawyer, T. K., Cone, R. D., & Schwendeman, S. P. (2023). Aqueous remote loading of setmelanotide in poly(lactic-co-glycolic acid) microspheres for long-term obesity treatment. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2023.09.015

Vancouver

Wang S, Downing G, Olsen KF, Sawyer TK, Cone RD, Schwendeman SP. Aqueous remote loading of setmelanotide in poly(lactic-co-glycolic acid) microspheres for long-term obesity treatment. Journal of Controlled Release. 2023. doi:10.1016/j.jconrel.2023.09.015

BibTeX
@article{Wang2023,
  author = {Wang, Shuying and Downing, Griffin and Olsen, Karl F and Sawyer, Tomi K and Cone, Roger D and Schwendeman, Steven P},
  title = {Aqueous remote loading of setmelanotide in poly(lactic-co-glycolic acid) microspheres for long-term obesity treatment},
  journal = {Journal of Controlled Release},
  year = {2023},
  doi = {10.1016/j.jconrel.2023.09.015}
}
Kostenlos starten →